US-based Decision Resources Group has made its first overseas purchase, acquiring UK health economics consultant Abacus International. Terms were not disclosed. More

Mumbai, India-based pharmaceutical product manufacturer Piramal Healthcare is to acquire US-based pharma research firm Decision Resources Group (DRG) for around $635m. More

In the US, Decision Resources has acquired consulting and MR firm PharmaStrat, a specialist in reimbursement and organized customer segments for biopharma manufacturers; and has also announced a change of name. More

US pharma and healthcare specialist Decision Resources has relocated its headquarters from Waltham to Burlington, Massachusetts, in preparation for future growth. More

US pharma and healthcare specialist Decision Resources has launched an interactive web-based platform that allows users to search for 'product analogues' - modified drugs based on the structure of existing medicine - and assess potential market opportunities. More

US pharmaceutical and health care specialist Decision Resources has acquired BioTrends Research Group, which provides syndicated and custom market research services to mid-size pharma markets. Terms were not disclosed. More

US pharma and healthcare research firm Decision Resources has restructured into two segments - Biopharma and Medical Technology - and made a number of promotions accordingly. More

US-based healthcare market research provider Decision Resources is expanding its Physician and Payer Forum product line to include primary research on European attitudes towards cancer drugs on the market. More

In the US, healthcare market research firm Decision Resources has acquired physician and consumer opinions agency Manhattan Research. Terms of the deal were not disclosed. More

US-based healthcare specialist Decision Resources, Inc. has boosted its managed care franchise with the acquisition of Fingertip Formulary, which provides access to and insight into formulary data in the United States. More

Pharmaceutical and healthcare insight firm Decision Resources, Inc. has acquired Arlington Medical Resources, Inc. (AMR), a provider of market intelligence for the pharma and diagnostic imaging industries. More

In the US, pharma research firm Decision Resources has announced plans to acquire the Life Sciences business of Wood Mackenzie, which comprises market research, data and analysis on the biopharmaceutical and animal health industries. Terms of the deal were not disclosed. More

US pharma research firm Decision Resources has followed up its recent cash injection with the appointment of former Thomson Healthcare Executive VP Shahir Kassam-Adams as Chief Strategy Officer, charged with managing its acquisition plans. More

Pharma research firm Decision Resources has announced that Providence Equity Partners has acquired majority control in the company. The firm says it will use the cash to fund its growth. More

US agencies Decision Resources and PharMetrics are to work together on a new interactive product, DecisionMETRICS™, to enhance the way pharmaceutical companies analyze their disease markets. More

15 articles found.